Nasopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients
A completed clinical trial evaluating 68Ga-FAPI-46 PET/CT to predict response to neoadjuvant therapy in nasopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Somatostatin Receptor Imaging in NPC, EBV Related Cancers [NA]
This clinical trial update reports completion of a study on somatostatin receptor imaging in nasopharyngeal cancer and Epstein-Barr virus-re…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer [Phase 2]
A Phase 2 clinical trial is evaluating JMT101 in combination with mitoxantrone liposome for recurrent or metastatic nasopharyngeal cancer an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC) [Phase 3]
Phase 3 trial evaluating tislelizumab plus chemotherapy versus chemotherapy alone in recurrent or metastatic Nasopharyngeal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]
Phase Ib trial of buparlisib (BKM120) with cisplatin and radiotherapy in high-risk locally advanced squamous cell carcinoma of the head and …
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer [Phase 3]
Phase 3 trial update evaluating a triple antiemetic regimen for chemoradiotherapy in cervical cancer or nasopharyngeal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial update exploring the combination of radiotherapy with immunotherapy and chemotherapy for metastatic nasopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in [Phase 2]
Phase II safety run-in for 177Lu-DOTATATE in metastatic nasopharyngeal cancer is being studied; results not yet available.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating tranilast as a radiosensitizer for re-irradiation in recurrent nasopharyngeal carcinoma is ongoing, with…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and paclitaxel for locally recurrent or metastatic nasopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating maintenance therapy with apatinib after chemoradiotherapy in metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating sintilimab with chemoradiotherapy for locoregionally-advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy [Phase 3]
Phase 3 trial evaluating adjuvant chemotherapy in nasopharyngeal cancer patients with residual Epstein-Barr virus DNA after radiotherapy.
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer [Phase 1, Phase 2]
A clinical trial update for TQB2858 in recurrent/metastatic nasopharyngeal cancer; phase 1 and phase 2 studying safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial assessing GP/FP regimens in advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy [Phase 2]
Phase 2 clinical trial assessing a recombinant EBV vaccine for nasopharyngeal cancer patients with residual EBV DNA after standard therapy.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update for toripalimab in local-regional recurrent nasopharyngeal carcinoma; recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) [Phase 2]
Phase 2 trial update on sequential and concurrent chemoradiation for advanced nasopharyngeal carcinoma has completed enrollment with results…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT [Phase 3]
Phase 3 trial comparing surgery versus IMRT for early recurrent nasopharyngeal cancer, status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating concurrent and adjuvant PD-1 treatment with chemo-radiotherapy in high-risk nasopharyngeal carcinoma is currently r…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions [Phase 2]
Phase 2 clinical trial update on oligo-metastatic nasopharyngeal cancer treated with radiation to primary tumors and treatment to metastatic…
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients [Phase 4]
A Phase 4 clinical trial compares transdermal fentanyl and morphine for oral mucositis pain in nasopharyngeal cancer patients undergoing tre…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors [Phase 2]
Phase 2 clinical trial update for DC-CIK immunotherapy in solid tumors; current status is unknown.